These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28851772)

  • 1. Determining the sample size required to establish whether a medical device is non-inferior to an external benchmark.
    Sayers A; Crowther MJ; Judge A; Whitehouse MR; Blom AW
    BMJ Open; 2017 Aug; 7(8):e015397. PubMed ID: 28851772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the non-inferiority of prosthesis constructs used in hip replacement using data from the National Joint Registry of England, Wales, Northern Ireland and the Isle of Man: a benchmarking study.
    Deere KC; Whitehouse MR; Porter M; Blom AW; Sayers A
    BMJ Open; 2019 Apr; 9(4):e026685. PubMed ID: 31036708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the non-inferiority of prosthesis constructs used in total and unicondylar knee replacements using data from the National Joint Registry of England, Wales, Northern Ireland and the Isle of Man: a benchmarking study.
    Deere KC; Whitehouse MR; Porter M; Blom AW; Sayers A
    BMJ Open; 2019 Apr; 9(4):e026736. PubMed ID: 31036709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are competing risks models appropriate to describe implant failure?
    Sayers A; Evans JT; Whitehouse MR; Blom AW
    Acta Orthop; 2018 Jun; 89(3):256-258. PubMed ID: 29521152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the Survivorship of Birmingham Hip Resurfacing Better Than Selected Conventional Hip Arthroplasties in Men Younger Than 65 Years of Age? A Study from the Australian Orthopaedic Association National Joint Replacement Registry.
    Stoney J; Graves SE; de Steiger RN; Rainbird S; Kelly TL; Hatton A
    Clin Orthop Relat Res; 2020 Nov; 478(11):2625-2636. PubMed ID: 32898048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals.
    Rehal S; Morris TP; Fielding K; Carpenter JR; Phillips PP
    BMJ Open; 2016 Oct; 6(10):e012594. PubMed ID: 27855102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Benchmarking Total Hip Arthroplasty Implants Using Data from the Michigan Arthroplasty Registry Collaborative Quality Initiative (MARCQI).
    Chubb HA; Cornish ER; Hallstrom BR; Hughes RE
    Orthop Res Rev; 2021; 13():215-228. PubMed ID: 34853539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing Risk of Death When Comparing Tibial Implant Types in Total Knee Arthroplasty.
    Maradit Kremers H; Kremers WK; Sierra RJ; Lewallen DG; Berry DJ
    J Bone Joint Surg Am; 2016 Apr; 98(7):591-6. PubMed ID: 27053588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benchmarking total hip replacement constructs using noninferiority analysis: the New Zealand joint registry study.
    Wyatt M; Frampton C; Whitehouse M; Deere K; Sayers A; Kieser D
    BMC Musculoskelet Disord; 2021 Aug; 22(1):719. PubMed ID: 34419036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis.
    Lacny S; Wilson T; Clement F; Roberts DJ; Faris PD; Ghali WA; Marshall DA
    Clin Orthop Relat Res; 2015 Nov; 473(11):3431-42. PubMed ID: 25804881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of non-inferiority randomized trials using the difference in restricted mean survival times.
    Weir IR; Trinquart L
    Clin Trials; 2018 Oct; 15(5):499-508. PubMed ID: 30074407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LUMiC
    Bus MP; Szafranski A; Sellevold S; Goryn T; Jutte PC; Bramer JA; Fiocco M; Streitbürger A; Kotrych D; van de Sande MA; Dijkstra PD
    Clin Orthop Relat Res; 2017 Mar; 475(3):686-695. PubMed ID: 27020434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Is the Long-term Survivorship of Primary and Revision Cemented Distal Femoral Replacements for Limb Salvage of Patients With Sarcoma?
    Geiger EJ; Arnold MT; Hart CM; Greig D; Trikha R; Sekimura T; Eckardt JJ; Bernthal NM
    Clin Orthop Relat Res; 2023 Mar; 481(3):460-471. PubMed ID: 35943730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proximal Humerus Tumors: Higher-than-Expected Risk of Revision With Constrained Reverse Shoulder Arthroplasty.
    Ayvaz M; Cetik RM; Bakircioglu S; Tokgozoglu AM
    Clin Orthop Relat Res; 2020 Nov; 478(11):2585-2595. PubMed ID: 32281773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Setting benchmark revision rates for total hip replacement: analysis of registry evidence.
    Kandala NB; Connock M; Pulikottil-Jacob R; Sutcliffe P; Crowther MJ; Grove A; Mistry H; Clarke A
    BMJ; 2015 Mar; 350():h756. PubMed ID: 25752749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When inferiority meets non-inferiority: implications for interim analyses.
    Bratton DJ; Williams HC; Kahan BC; Phillips PP; Nunn AJ
    Clin Trials; 2012 Oct; 9(5):605-9. PubMed ID: 22796636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Can We Learn From Surgeons Who Perform THA and TKA and Have the Lowest Revision Rates? A Study from the Australian Orthopaedic Association National Joint Replacement Registry.
    Hoskins W; Rainbird S; Lorimer M; Graves SE; Bingham R
    Clin Orthop Relat Res; 2022 Mar; 480(3):464-481. PubMed ID: 34677162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Are the Long-term Results of MUTARS
    Bus MP; van de Sande MA; Fiocco M; Schaap GR; Bramer JA; Dijkstra PD
    Clin Orthop Relat Res; 2017 Mar; 475(3):708-718. PubMed ID: 26649558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Large a Study Is Needed to Detect TKA Revision Rate Reductions Attributable to Robotic or Navigated Technologies? A Simulation-based Power Analysis.
    Hickey MD; Anglin C; Masri B; Hodgson AJ
    Clin Orthop Relat Res; 2021 Nov; 479(11):2350-2361. PubMed ID: 34351313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.